Facebook Pixel

Results of Telemonitoring and Self-Management in the Control of Hypertension (TASMINH2) Study

By Blogger
Rate This
High Blood Pressure related image

If you’ve ever been shopping and tried on one of those one-size-fits-all garments, then you know from first-hand experience that nothing could be farther from the truth - one-size does not truly “fit” all persons. We all have subtle differences (or maybe not so subtle!) that make the end result of wearing one of these one-size-fits-all garments a different experience for each of us. No two people are going to come out looking quite the same.

One of the complaints about Western medical care is that remedies are approached from a one-size-fits-all perspective. Pharmaceutical companies put out recommended dosage guidelines by age or weight or illness or whatever other criteria that the pharmaceutical powers-that-be deem are appropriate, and doctors dutifully prescribe the drugs at the recommended levels. The problem with this approach is that when it comes to our health, no two of us are exactly alike and one-size-fits-all approach may not produce the best results for all persons. For example, a normal temperature is generally accepted as 98.6 degrees. Most schools send children home at 100 degrees which is a full degree (plus a little) of temperature. But, there are people who run a consistent 97.6 degrees, which is their “normal.” At 99 degrees, they already have a full degree of temperature. By 100 degrees, they may be well on their way to a more serious illness.

Some medical professionals are beginning to wake up to the realization that our bodies are unique and that perhaps, just maybe, it might be prudent to start listening to a patient’s individual needs and adjust medicine dosages accordingly. One such study on hypertension, Telemonitoring and Self-Management in the Control of Hypertension (TASMINH2), examined the question of what happens when patients are allowed (under supervision, of course) to adjust medications according to pre-determined guidelines. (Study results were released in the July 8, 2010 edition of the Lancet.)

Conducted in the United Kingdom (UK), TASMINH2 was a long-term study with 480 participants.

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

High Blood Pressure

Get Email Updates

High Blood Pressure Guide

Have a question? We're here to help. Ask the Community.


Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!